High-risk factors for COVID- Think before you stop wearing MASKS!

Have you gone off mask? Well, it's time to rethink before you actually go ahead and drop all the COVID guards.

The last few months have been a sigh of relief with the COVID cases declining as we move towards normal life attending work and school. There has been a major ease in stepping out of the house without a mask. The transition from “with masks” to “without masks” has been witnessed by all of us worldwide. This article shall provide you with important highlights on why you should re-think before you go off the mask.

The fear of coronavirus is still alive 

The fear of coronavirus is still partially present due to many reasons which are as follows-

  • Mental block on being in isolation from 2020 to mid-2022
  • Human nature and thinking that COVID might hit back 
  • Dynamic action of the virus 

3 risks associated with COVID 

The major risk factors associated with COVID are as follows- 

COVID is not completely eliminated

Many countries still witness a surge in COVID cases. This virus is here to stay with us as per the recent update about China witnessing a surge in the number of COVID cases.

COVID affects many parts of the body 

Covid is not just a respiratory affection but is known to affect many organs causing comorbidity. Well, that's not all. Post covid syndrome may cause long-term problems like fatigue, weakness, and mental issues comprising of depression and anxiety. Covid affections are not just limited to the respiratory problem affecting the lungs but may also impact cognitive decline, kidney  issues, and cardiovascular problems. The World Health Organization (WHO) along with national health agencies have started working on addressing the other health concerns caused by COVID. 

The variants of COVID and its mutations 

The variants of COVID have remained and existed for more than a year. The virus is also known to be rapidly mutating. Several variants of the Omicron virus have been detected so far. This relates to the higher infectivity rate of coronavirus. Each variant of coronavirus has been shown to spread at a faster rate. The mutations found in the virus allow it to gets attached to cells easily. It has great evading ability which means it has a high capacity of reinfection. 

Tags : #highriskfactor #covid #covidinfection #stopwearingmask #smitakumar #medicircle #myhealth

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024